These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18467732)

  • 1. Interventions for alleviating cancer-related dyspnea: a systematic review.
    Ben-Aharon I; Gafter-Gvili A; Paul M; Leibovici L; Stemmer SM
    J Clin Oncol; 2008 May; 26(14):2396-404. PubMed ID: 18467732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis.
    Ben-Aharon I; Gafter-Gvili A; Leibovici L; Stemmer SM
    Acta Oncol; 2012 Nov; 51(8):996-1008. PubMed ID: 22934558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
    Afolabi TM; Nahata MC; Pai V
    Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of dyspnea in cancer patients: a systematic review.
    Viola R; Kiteley C; Lloyd NS; Mackay JA; Wilson J; Wong RK;
    Support Care Cancer; 2008 Apr; 16(4):329-37. PubMed ID: 18214551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review.
    Vargas-Bermúdez A; Cardenal F; Porta-Sales J
    J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic intervention for cancer-related dyspnea.
    Cuervo Pinna MA; Mota Vargas R; Redondo Moralo MJ; Correas MA
    J Clin Oncol; 2008 Sep; 26(25):4225; author reply 4226. PubMed ID: 18757344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological therapy of refractory dyspnoea : a systematic literature review].
    Simon ST; Köskeroglu P; Bausewein C
    Schmerz; 2012 Sep; 26(5):515-22. PubMed ID: 22956077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom control and palliative care: management of breathlessness.
    Oxberry SG; Lawrie I
    Br J Hosp Med (Lond); 2009 Apr; 70(4):212-6. PubMed ID: 19357599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized opioids to treat dyspnea.
    Chandler S
    Am J Hosp Palliat Care; 1999; 16(1):418-22. PubMed ID: 10085800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Dyspnea in Advanced Cancer: ASCO Guideline.
    Hui D; Bohlke K; Bao T; Campbell TC; Coyne PJ; Currow DC; Gupta A; Leiser AL; Mori M; Nava S; Reinke LF; Roeland EJ; Seigel C; Walsh D; Campbell ML
    J Clin Oncol; 2021 Apr; 39(12):1389-1411. PubMed ID: 33617290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nebulized and intranasal opioids for the relief of breathlessness.
    Bausewein C; Simon ST
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Dyspnea in the Terminally Ill.
    Pisani L; Hill NS; Pacilli AMG; Polastri M; Nava S
    Chest; 2018 Oct; 154(4):925-934. PubMed ID: 29679597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
    Luo N; Tan S; Li X; Singh S; Liu S; Chen C; Huang Z; Feng S; Lin Y; Lin Y; Cen H; Liang M; Chen M
    J Pain Symptom Manage; 2021 Jan; 61(1):198-210.e1. PubMed ID: 32730950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
    J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dyspnea in lung cancer].
    Bonnichon A; Le Floch H; Rivière F; Staub E; Mairovitz A; Marotel C; Vaylet F; Margery J
    Rev Pneumol Clin; 2008 Apr; 64(2):62-8. PubMed ID: 18589285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer.
    Yasuda S; Sugano K; Matsuda Y; Kako J; Takagi Y; Watanabe H; Kasahara Y; Goya S; Kohara H; Mori M; Nakayama T; Yamaguchi T
    Jpn J Clin Oncol; 2023 Mar; 53(4):327-334. PubMed ID: 36636762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.
    Strieder M; Pecherstorfer M; Kreye G
    Wien Med Wochenschr; 2018 Oct; 168(13-14):333-343. PubMed ID: 28921042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
    Gamborg H; Riis J; Christrup L; Krantz T
    J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
    Maeda T; Hayakawa T
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.